Edinburgh: Scotland has kicked off a new center to produce and sell human stem cells; Roslin Cells Center is a pioneering $4 million project, the first ever in Europe, envisaged to give an impetus to the many organizations dedicated to stem cell research. The Roslin Cells Center is a brain child of four committed companies - The Roslin Institute, Scottish Enterprise, Edinburgh University and the Scottish National Blood Transfusion Service.
Donated eggs and embryos will form the basis of creation of human stem cells. These cells will be sold to stem research outfits and researchers. The pricing will be extremely soft, dictated by a non-profit motive. The center will be a hotbed for testing drugs and evolving new medicines, to find answers for chronic diseases like diabetes and leukemia.
Neil Francis, deputy chief executive of Scottish Enterprise Edinburgh and Lothian, said, "As well as having huge potential to make significant breakthroughs in the treatment of some of the most debilitating diseases, the stem cell sector has the potential to become one of the key drivers of Scotland's knowledge economy."